Heterocyclic molecules as apoptosis inducers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8946445
APP PUB NO 20140256768A1
SERIAL NO

14351479

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present document describes novel compounds which may inhibit the activity of anti-apoptotic proteins such as Bcl-2 family protein members, compositions containing the compounds and methods of treating diseases involving a defect in apoptosis, such as, for example, in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BETA PHARMA CANADA INC6100 AVENUE ROYALMOUNT MONTREAL QUEBEC H4P 2R2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wang, Zhaoyin Kirkland, CA 73 1827

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00